Biblio

Found 22 results
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Hardy, John  [Clear All Filters]
Journal Article
Busby V, Goossens S, Nowotny P, Hamilton G, Smemo S, Harold D, Turic D, Jehu L, Myers A, Womick M et al..  2004.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.. Neuromolecular Med. 5(2):133-46.
Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, Mayeux R, Shen L, Kim S, Turk M et al..  2012.  Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. PLoS One. 7(12):e50640.
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K et al..  2010.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.
Nowotny P, Hinrichs AL, Smemo S, Kauwe JSK, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P et al..  2005.  Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.. Am J Med Genet B Neuropsychiatr Genet. 136B(1):62-8.
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JSingh, Moskvina V et al..  2011.  Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet. 43(5):429-35.
Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, San Wang L- et al..  2014.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ et al..  2007.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.. Neuron. 54(5):713-20.
Desikan RS, Fan CChieh, Wang Y, Schork AJ, Cabral HJ, L Cupples A, Thompson WK, Besser L, Kukull WA, Holland D et al..  2017.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.. PLoS Med. 14(3):e1002258.
Webster JA, J Gibbs R, Clarke J, Ray M, Zhang W, Holmans P, Rohrer K, Zhao A, Marlowe L, Kaleem M et al..  2009.  Genetic control of human brain transcript expression in Alzheimer disease.. Am J Hum Genet. 84(4):445-58.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A et al..  2019.  Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet. 51(3):414-430.
Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel J-P, Younkin SG et al..  2014.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.. PLoS Genet. 10(9):e1004606.
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JSingh, Moskvina V, Dowzell K, Williams A et al..  2009.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.. Nat Genet. 41(10):1088-93.
Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, San Wang L-, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE et al..  2011.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.
Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CHong, Kouri N, Ross OA, Höglinger GU, Müller U et al..  2018.  Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.. PLoS Med. 15(1):e1002487.
Guerreiro R, Brás J, Hardy J, Singleton A.  2014.  Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.. Hum Mol Genet. 23(R1):R47-53.
Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen C-H et al..  2015.  Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.. Circulation. 131(23):2061-2069.
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC et al..  2017.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.. Nat Genet. 49(9):1373-1384.
Cruchaga C, Karch CM, Jin SChih, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S et al..  2014.  Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.. Nature. 505(7484):550-554.
Myers AJ, J Gibbs R, Webster JA, Rohrer K, Zhao A, Marlowe L, Kaleem M, Leung D, Bryden L, Nath P et al..  2007.  A survey of genetic human cortical gene expression.. Nat Genet. 39(12):1494-9.
Smemo S, Nowotny P, Hinrichs AL, Kauwe JSK, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM et al..  2006.  Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.. Ann Neurol. 59(1):21-6.
Myers AJ, Marshall H, Holmans P, Compton D, Crook RJP, Mander AP, Nowotny P, Smemo S, Dunstan M, Jehu L et al..  2004.  Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.. Am J Med Genet B Neuropsychiatr Genet. 124B(1):29-37.